The Interactions of Nintedanib and Oral Anticoagulants—Molecular Mechanisms and Clinical Implications

Nintedanib is a synthetic orally active tyrosine kinase inhibitor, whose main action is to inhibit the receptors of the platelet-derived growth factor, fibroblast growth factor and vascular endothelial growth factor families. The drug also affects other kinases, including Src, Flt-3, LCK, LYN. Ninte...

Descripción completa

Detalles Bibliográficos
Autores principales: Grześk, Grzegorz, Woźniak-Wiśniewska, Anita, Błażejewski, Jan, Górny, Bartosz, Wołowiec, Łukasz, Rogowicz, Daniel, Nowaczyk, Alicja
Formato: Online Artículo Texto
Lenguaje:English
Publicado: MDPI 2020
Materias:
Review
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795697/
https://www.ncbi.nlm.nih.gov/pubmed/33396592
http://dx.doi.org/10.3390/ijms22010282

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7795697/
https://www.ncbi.nlm.nih.gov/pubmed/33396592
http://dx.doi.org/10.3390/ijms22010282

Ejemplares similares